MedPath

Effect of shiva guggulu tablets and kottam chukkadi taila in management of Amavata (one type of joint disorder)

Not yet recruiting
Conditions
patients suffering from Rheumatoid Arthritis
Registration Number
CTRI/2014/04/004531
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Rheumatoid Arthritis is a clinical condition characterized by inflamation of synovial membrane . it closely resembles with Amavata mentioned in Ayurvedic classics madhava nidana. Shiva guggulu as a internal medication and Kottam chukkadi Taila as a local application are helpful to manage the disease  Rheumatoid Arthriti but it takes long time to control the symptoms. contents of Shiva Guggulu and Kottam Chukkadi as below. **A.** ***SHIVA GUGGULU******:-***

| | | | |

| --- | --- | --- | --- |

|***No.***

***Name(Latin Name)***

***Part Used***

***Proportion***

|**1.**

Haritaki (Terminalia chebula)Fruit

1 part

|**2.**

*Bibhitaka (Terminalia bellirica**)*

Fruit

1 part

|**3.**

*Amalaki (Emblica officinalis)*

Fruit

1 part

|**4.**

*Erand Taila(Ricinus communis)*

Oil

1/2 part

|**5.**

*Suddha Gandhaka(Sulphur)*

-

1/5  part

|**6.**

*Suddha Guggulu(Commiphora mukul)*

Resin

1/2part

|**7.**

*Rasna (Pluchea lanceolata)*

Whole plant

1/32  part

|**8.**

*Vidanga (Embelia ribes)*

Fruit

1/32  part

|**9.**

*Maricha (Piper nigrum)*

Fruit

1/32  part

|**10.**

*Pippali (Piper longum)*

Fruit

1/32  part

|**11.**

*Danti (Baliospermum montanum)*

Root

1/32  part

|**12.**

*Jatamansi (Nardostachys jatamansi)*

Rhizome

1/32  part

|**13.**

*Nagar (Zingiber officinale)*

Rhizome

1/32  part

|**14.**

*Devadaru (Cedrus deodara)*

Heart wood

1/32  part

---

***KOTTAM CHUKKADI TAILA***. The ingredients of ***Kottam Chukkadi Taila*** are as follow;

| | | | |

| --- | --- | --- | --- |

|***No.***

***Name(Latin Name)***

***Part Used***

***Proportion***

|***1.***

*Kushtha (Saussurea lappa)*

Root

1 part

|***2.***

*Shunthi (Zingiber officinale)*

Rhizome

1 part

|***3.***

*Vacha (Acorus calamus)*

Rhizome

1 part

|***4.***

*Shigru (Moringa oliefera)*

Stem bark

1 part

|***5.***

*Lashuna (Alium sativum)*

Bulb

1 part

|***6.***

*Himstra (Capparis sepiaria)*

Root

1 part

|***7.***

*Devadaru (Cedrus deodara)*

Ht.wood

1 part

|***8.***

*Sarshapa (Brassica campestries)*

Seeds

1 part

|***9.***

*Rasna (Vanda roxburghai)*

Whole plant

1 part

|***10.***

*Tila(Sesamum indicum)*

Oil

32 part

|***11.***

*Godadhi(curd)*

-

32 part

|***12***

*Chincha (Tamarindus indica)*

Leaves

1/7  part

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

patients fulfilling the diagnostic criteria Age between 20 to 60 years willing and able to participate in the study.

Exclusion Criteria

Chronicity more than 10 years A patients who have severe complications of Rheumatoid Arthritis A patients having gouty Arthritis poorly controlled HTN And DM Patients on prolong allopathy medication like steroids pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
etc.60 days
subjective and objective criteria.60 days
The effect will be assessed on the basis of60 days
Improvement in the signs and symptoms will be60 days
symptomatology.60 days
appraised on the basis of special adopted60 days
Changes in RA factor and CRP60 days
scoring pattern for scrutinizing the60 days
Improvement in Hand grip walking time foot pressure60 days
Secondary Outcome Measures
NameTimeMethod
The effect will be assessed on the basis ofsubjective and objective criteria.

Trial Locations

Locations (1)

Dept. of Kayachikitsa

🇮🇳

Jamnagar, GUJARAT, India

Dept. of Kayachikitsa
🇮🇳Jamnagar, GUJARAT, India
Dr Altaf Sherasia
Principal investigator
9033457226
dr.altaf16@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.